自我調節止痛法 (PCA) 市場:2015年
Patient Controlled Analgesia
|出版商||Greystone Research Associates||商品編碼||332544|
|自我調節止痛法 (PCA) 市場:2015年 Patient Controlled Analgesia|
|出版日期: 2015年06月11日||內容資訊: 英文||
本報告提供自我調節止痛法 (PCA) 市場相關調查、疼痛管理市場趨勢與PCA設備的概要與適應、市場資料與預測、參與企業簡介彙整。
An increasing understanding of the physiology of pain coupled with patient-friendly dosage forms and delivery techniques is providing caregivers and prescribers with improved tools for helping patient manage their own pain. New and emerging pain delivery products that allow patients to play an active role in the timing and dosing of their pain medication allow patients to balance pain relief and medication side effects, and potentially improve quality-of-life. Pain management philosophy is based on the premise of treating pain early and aggressively. This is based on research that pain is tightly correlated with decreased quality of life, and increased incidence of anxiety and depression. Further, pain causes the physiologic release of destructive enzymes that can damage even healthy tissue. The aging population - particularly in North America and Western Europe, where the quality of medical care is high and consumers enjoy a relatively high standard of living - will create a growing market of mature and elderly needing drug therapies and pain management for a variety of maladies associated with the aging process. These factors are attracting well-financed players and elevating alliance activity in this sector.